Product Name: Human GPR73 / PROKR1 Antibody (Regeneron patent anti-PROKR1, Research Use)
Catalog Number: NBR-0485
Target Name: GPR73 / PROKR1
Trade Name: Regeneron patent anti-PROKR1
Antibody Drug Description: The drug is a recombinant fully human anti-PROKR1 monoclonal antibody, being developed by Regeneron. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: PROKR1
Synonyms: GPR73; GPR73a; PKR1; ZAQ
Target Description: Receptor for prokineticin 1. Exclusively coupled to the G(q) subclass of heteromeric G proteins. Activation leads to mobilization of calcium, stimulation of phosphoinositide turnover and activation of p44/p42 mitogen-activated protein kinase. 
Ensembl: ENSG00000169618
Uniprot: Q8TCW9